| Richard Walter, DO | |
|
1813 Willow St, Suite 5 B, Vincennes, IN 47591-4267 | |
| (812) 882-2703 | |
| (812) 882-2760 |
| Full Name | Richard Walter |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1813 Willow St, Vincennes, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114927886 | NPI | - | NPPES |
| 100427420 | Medicaid | IN | |
| 000000847454 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 02000873 (Indiana) | Primary |
| Entity Name | Good Samaritan Hospital Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649432071 PECOS PAC ID: 3971671330 Enrollment ID: O20081013000182 |
News Archive
New research shows that levels of C-reactive protein (CRP), produced by the liver and not at the lesion site, correlate with the degree of atherosclerosis.
People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below had fewer heart attacks, strokes and other diabetes complications, according to a study published in the American Heart Association's journal Hypertension.
A new study shows that a protein found in blood alleviates anemia, a condition in which the body's tissues don't get enough oxygen from the blood. In this animal study, injections of the protein, known as transferrin, also protected against potentially fatal iron overload in mice with thalassemia, a type of inherited anemia that affects millions of people worldwide.
The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.
In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Walter, DO 1813 Willow St, Suite 5 B, Vincennes, IN 47591-4267 Ph: (812) 882-2703 | Richard Walter, DO 1813 Willow St, Suite 5 B, Vincennes, IN 47591-4267 Ph: (812) 882-2703 |
News Archive
New research shows that levels of C-reactive protein (CRP), produced by the liver and not at the lesion site, correlate with the degree of atherosclerosis.
People with type 2 diabetes who received intensive treatment to keep their blood pressure levels at 130/80 mm/Hg or below had fewer heart attacks, strokes and other diabetes complications, according to a study published in the American Heart Association's journal Hypertension.
A new study shows that a protein found in blood alleviates anemia, a condition in which the body's tissues don't get enough oxygen from the blood. In this animal study, injections of the protein, known as transferrin, also protected against potentially fatal iron overload in mice with thalassemia, a type of inherited anemia that affects millions of people worldwide.
The U.S. Food and Drug Administration today approved the first ultrasound device for use in combination with a standard mammography in women with dense breast tissue who have a negative mammogram and no symptoms of breast cancer.
In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.
› Verified 5 days ago
Dr. Alan D Stewart, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 520 S 7th St, Vincennes, IN 47591 Phone: 812-885-3601 Fax: 812-885-3614 | |
Mr. Elias Victor I Impens, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 520 S 7th St, Vincennes, IN 47591 Phone: 812-882-5220 Fax: 812-885-3917 | |
Mark E. Pajeau, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 520 S 7th St, Vincennes, IN 47591 Phone: 812-886-6565 Fax: 812-886-6566 | |
Andrei Mihai Croitoru, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 520 S 7th St, Good Samaritan Hospital, Vincennes, IN 47591 Phone: 812-885-2500 | |
Renee L Bartlett, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 520 S 7th St, Vincennes, IN 47591 Phone: 812-886-6565 Fax: 812-886-6566 | |
Billy Powell Jr., MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 520 S 7th St, Vincennes, IN 47591 Phone: 812-882-5220 |